Lyme Disease

Awarded Project: "Defining Protective and Disease-Reducing Immunity to Borrelia Burgdorferi Infection"

September 30, 2018
Defining Protective and Disease-Reducing Immunity to Borrelia Burgdorferi Infection  

Dr. Nicole Baumgarth was awarded a three year project through the DoD Congressionally Directed Medical Research Program to work on a Lyme disease study.   Following infection with Borrelia burgdorferi, the causative agent of Lyme disease, antibodies are generated that can reduce the number of Borrelia in the infected host, but they cannot totally eliminate the infection.

Awarded Project: "Defining protective antibody-mediated immunity to Borrelia burgdorferi"

March 21, 2018
Defining protective antibody-mediated immunity to Borrelia burgdorferi 

Dr. Nicole Baumgarth was awarded a one year grant from the Global Lyme Alliance, Inc. The goal of the project is to reveal the antibacterial properties of antibodies generated in response to infection of mice with Borrelia burgdorferi, the causative agent of Lyme disease in humans, and thereby to elucidate immune evasion mechanisms that allow B. burgdorferi to establish persistent infection in its reservoir host species.  

Awarded Project: "Cohen Lyme Project"

December 31, 2015
Cohen Lyme Project

Dr. Nicole Baumgarth was awarded a four year grant from the Steven & Alexandra Cohen Foundation to study Lyme disease.  The goal of this project is to determine the role of immune response suppression in the outcome of Borrelia burgdorferi infection and to device strategies to device  strategies to overcome ineffective immunity to this pathogen.